150 related articles for article (PubMed ID: 2731314)
1. Intracellular metabolites of cisplatin in the rat kidney.
Mistry P; Lee C; McBrien DC
Cancer Chemother Pharmacol; 1989; 24(2):73-9. PubMed ID: 2731314
[TBL] [Abstract][Full Text] [Related]
2. A study of the protective effect of chloride salts on cisplatin nephrotoxicity.
Daley-Yates PT; McBrien DC
Biochem Pharmacol; 1985 Jul; 34(13):2363-9. PubMed ID: 4040367
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Pt in the urine and kidney of the cisplatin treated rat.
Mason RW; Hogg SJ; Edwards IR
Toxicology; 1986 Feb; 38(2):219-26. PubMed ID: 3945972
[TBL] [Abstract][Full Text] [Related]
4. The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney.
Mistry P; Merazga Y; Spargo DJ; Riley PA; McBrien DC
Cancer Chemother Pharmacol; 1991; 28(4):277-82. PubMed ID: 1879045
[TBL] [Abstract][Full Text] [Related]
5. Uptake and metabolism of cisplatin by rat kidney.
Safirstein R; Miller P; Guttenplan JB
Kidney Int; 1984 May; 25(5):753-8. PubMed ID: 6540826
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin.
Daley-Yates PT; McBrien DC
Biochem Pharmacol; 1984 Oct; 33(19):3063-70. PubMed ID: 6541482
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.
Stewart DJ; Dulberg C; Molepo JM; Mikhael NZ; Montpetit VA; Redmond MD; Goel R
Cancer Chemother Pharmacol; 1994; 34(1):14-22. PubMed ID: 8174197
[TBL] [Abstract][Full Text] [Related]
8. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
Nagai N; Hotta K; Yamamura H; Ogata H
Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidney.
Hanigan MH; Gallagher BC; Taylor PT
Am J Obstet Gynecol; 1996 Aug; 175(2):270-3; discussion 273-4. PubMed ID: 8765241
[TBL] [Abstract][Full Text] [Related]
10. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats.
Zicca A; Cafaggi S; Mariggiò MA; Vannozzi MO; Ottone M; Bocchini V; Caviglioli G; Viale M
Eur J Pharmacol; 2002 May; 442(3):265-72. PubMed ID: 12065080
[TBL] [Abstract][Full Text] [Related]
11. Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity.
Stewart DJ; Mikhael NZ; Nanji AA; Nair RC; Kacew S; Howard K; Hirte W; Maroun JA
J Clin Oncol; 1985 Sep; 3(9):1251-6. PubMed ID: 4040958
[TBL] [Abstract][Full Text] [Related]
12. The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin.
Uozumi J; Litterst CL
Cancer Lett; 1986 Sep; 32(3):279-83. PubMed ID: 3768854
[TBL] [Abstract][Full Text] [Related]
13. Time course of the binding of platinum to subfractions of the kidney cytosol in the cisplatin-treated rat.
Mason R; Hogg S; Edwards IR
Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):51-8. PubMed ID: 3715197
[TBL] [Abstract][Full Text] [Related]
14. Interactions of cis-platinum with cellular zinc and copper in rat liver and kidney tissues.
Sharma RP
Pharmacol Res Commun; 1985 Feb; 17(2):197-206. PubMed ID: 4039454
[TBL] [Abstract][Full Text] [Related]
15. The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.
Daley-Yates PT; McBrien DC
Biochem Pharmacol; 1985 May; 34(9):1423-8. PubMed ID: 4039567
[TBL] [Abstract][Full Text] [Related]
16. Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: possible role in nephrotoxicity.
Litterst CL; Schweitzer VG
Res Commun Chem Pathol Pharmacol; 1988 Jul; 61(1):35-48. PubMed ID: 3175342
[TBL] [Abstract][Full Text] [Related]
17. The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.
Uozumi J; Litterst CL
J Pharmacobiodyn; 1988 Apr; 11(4):277-83. PubMed ID: 3411443
[TBL] [Abstract][Full Text] [Related]
18. Interaction of platinum with metallothionein-like ligands in the rat kidney after administration of cis-dichlorodiammine platinum II.
Mason R; Edwards IR; McLaren SJ
Chem Biol Interact; 1984 Apr; 49(1-2):165-76. PubMed ID: 6539175
[TBL] [Abstract][Full Text] [Related]
19. Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin.
Safirstein R; Daye M; Guttenplan JB
Cancer Lett; 1983 Apr; 18(3):329-38. PubMed ID: 6682696
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of unchanged cisplatin in rat kidney and liver by high-performance liquid chromatography.
Hanada K; Nagai N; Ogata H
J Chromatogr B Biomed Appl; 1995 Jan; 663(1):181-6. PubMed ID: 7704209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
